Genetics Generation Advancement Corp. (4160.TWO)

TWD 64.7

(0.31%)

Net Debt Summary of Genetics Generation Advancement Corp.

Genetics Generation Advancement Corp.'s latest annual net debt in 2023 was -79.18 Million TWD , down -46.32% from previous year.
Genetics Generation Advancement Corp.'s latest quarterly net debt in 2024 Q2 was -50.2 Million TWD , up 55.7% from previous quarter.
Genetics Generation Advancement Corp. reported annual net debt of -54.11 Million TWD in 2022, up 34.69% from previous year.
Genetics Generation Advancement Corp. reported annual net debt of -82.86 Million TWD in 2021, down -41.78% from previous year.
Genetics Generation Advancement Corp. reported quarterly net debt of -50.2 Million TWD for 2024 Q2, up 55.7% from previous quarter.
Genetics Generation Advancement Corp. reported quarterly net debt of -79.18 Million TWD for 2023 FY, down -46.32% from previous quarter.

Annual Net Debt Chart of Genetics Generation Advancement Corp. (2023 - 2019)

Historical Annual Net Debt of Genetics Generation Advancement Corp. (2023 - 2019)

Year	Net Debt	Net Debt Growth
2023	-79.18 Million TWD	-46.32%
2022	-54.11 Million TWD	34.69%
2021	-82.86 Million TWD	-41.78%
2020	-58.44 Million TWD	-53.61%
2019	-38.04 Million TWD	0.0%

Year	Net Debt	Net Debt Growth
2024 Q1	-113.33 Million TWD	-43.13%
2024 Q2	-50.2 Million TWD	55.7%
2023 FY	-79.18 Million TWD	-46.32%
2023 Q4	-79.18 Million TWD	-55.75%
2023 Q3	-50.84 Million TWD	27.87%
2023 Q2	-70.48 Million TWD	-91.54%
2023 Q1	-36.79 Million TWD	0.0%
2022 Q4	- TWD	0.0%
2022 FY	-54.11 Million TWD	34.69%
2021 FY	-82.86 Million TWD	-41.78%
2020 FY	-58.44 Million TWD	0.0%

Peer Net Debt Comparison of Genetics Generation Advancement Corp.

Name	Net Debt	Net Debt Difference
BIONET Corp.	-193.47 Million TWD	59.074%
DIVA Laboratories, Ltd.	-534.39 Million TWD	85.183%
Welgene Biotech Co.,Ltd.	-33.78 Million TWD	-134.387%
Puriblood Medical Co., Ltd.	-65.84 Million TWD	-20.264%
TFBS Bioscience Inc.	-797.57 Million TWD	90.072%